108 studies found for:    the EX-IMPROVE Study
Show Display Options
Rank Status Study
1 Recruiting Improvement of Patients With Chronic Heart Failure Using NT-proBNP
Condition: Congestive Heart Failure
Intervention: Other: NT-proBNP guided care
2 Completed Using Pharmacogenetics to Improve Treatment in Early-onset Diabetes
Condition: Diabetes
Intervention: Other: patient care pathway
3 Completed
Has Results
A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment
Condition: HIV Infections
Interventions: Drug: Kaletra + Current Dual NRTI Backbone;   Drug: Current Regimen
4 Completed
Has Results
ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)?
Conditions: Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2
Interventions: Device: Aviva Expert blood glucose meter;   Device: Aviva Nano blood glucose meter
5 Recruiting Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers
Conditions: Solid Tumors;   Acute Kidney Injury
Intervention: Biological: Mesenchymal stromal cell infusion
6 Completed
Has Results
A Study of MVA85A in Healthy Infants
Condition: Tuberculosis
Interventions: Biological: MVA85A/AERAS-485;   Biological: Candida Skin Test Antigen
7 Recruiting Randomized Trial in knEe Osteoarthritis Using Low Intensity Ultrasound - Evaluating Feasibility (RELIEF)
Condition: Knee Osteoarthritis
Interventions: Device: low intensity, pulsed ultrasound;   Device: sham ultrasound
8 Terminated Effects of Dual Cyclooxygenase-2 and Carbonic Anhydrase Inhibition
Condition: Healthy Volunteers
Interventions: Drug: CG100649 (2 mg);   Drug: Celecoxib;   Drug: Placebo capsules;   Drug: Naproxen;   Drug: Acetazolamide;   Drug: CG100649 (8 mg)
9 Recruiting Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy
Conditions: Follicular Lymphoma;   Follicular Non-Hodgkin´s Lymphoma;   Autologous Effector Lymphocytes
Intervention: Biological: Autologous effector lymphocytes expanded ex-vivo
10 Completed Neuromuscular Electrical Stimulation and Isokinetic Training
Condition: Healthy
Interventions: Device: NMES;   Other: Isokinetic exercise
11 Completed Detection of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity in Rectal Tissues From Human Subjects
Condition: Cystic Fibrosis
Intervention:
12 Active, not recruiting Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
Conditions: Autoimmune Diseases of the Nervous System;   Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis;   Disease Progression;   Brain Atrophy
Interventions: Biological: Tcelna;   Biological: Placebo
13 Completed Study of Mobile Phone Support for the DC Tobacco Quitline
Condition: Smoking Cessation
Interventions: Behavioral: Mobile EX cessation support;   Behavioral: DC Quitline Support;   Behavioral: Device Control
14 Completed A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally
Condition: HIV Prevention
Interventions: Drug: Rectal formulation (RF) of tenofovir 1% gel;   Drug: Vaginal formulations (original VF and reduced vaginal glycerin formulation RGVF) of tenofovir 1% gel;   Drug: Universal HEC Placebo Gel Formulation
15 Unknown  Craving and Lifestyle Management Through Mindfulness Pilot Study
Condition: Obesity
Intervention: Behavioral: Craving and Lifestyle Management through Mindfulness(CALMM+)
16 Withdrawn Infusion of Expanded Cord Blood T Cells
Conditions: Stem Cell Transplantation;   Leukemia;   Lymphoma;   Pediatric Disorders
Interventions: Radiation: Total Body Irradiation (TBI);   Drug: Melphalan;   Drug: Thiotepa;   Drug: Fludarabine;   Drug: Rituximab;   Drug: Etoposide;   Drug: Anti-thymocyte globulin (ATG);   Drug: Mycophenolate Mofetil (MMF);   Drug: Tacrolimus;   Procedure: Cord Blood Infusion;   Drug: G-CSF;   Procedure: Ex vivo expanded T cell Infusion
17 Completed
Has Results
An International Study to Evaluate Recombinant Interleukin-2 in HIV Positive Patients Taking Anti-retroviral Therapy
Condition: HIV Infections
Intervention: Drug: Recombinant interleukin-2 (rIL-2)
18 Active, not recruiting Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
Conditions: Hematologic Malignancies;   Acute Myeloid Leukemia;   Lymphoid Leukemia;   Chronic Myeloid Leukemia;   Hodgkin's Disease;   Non-Hodgkin's Lymphoma;   Myelodysplastic Syndromes
Intervention: Drug: StemEx®
19 Completed Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination
Condition: Tuberculosis
Interventions: Biological: BCG;   Drug: Isoniazid
20 Enrolling by invitation Telehealth Remote Patient Monitoring Study in People With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Behavioral: Patient education, self-monitoring of blood glucose and remote patient monitoring of blood glucose

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years